Skip to main content Back to Top
Advertisement

9/2/2023

Timolol Ophthalmic Solution

Products Affected - Description

    • Timoptic Ocumeter Plus, Bausch Health, 0.25%, 5 mL bottle, 1 count, NDC 24208-0812-05 - discontinued
    • Timoptic Ocumeter Plus, Bausch Health, 0.5%, 10 mL bottle, 1 count, NDC 24208-0813-10 - discontinued
    • Timoptic Ocumeter Plus, Bausch Health, 0.5%, 5 mL bottle, 1 count, NDC 24208-0813-05 - discontinued

Reason for the Shortage

    • Akorn discontinued timolol ophthalmic solution in early-2022.
    • Apotex has timolol available.
    • Bausch Health did not provide a reason for the shortage. The Timoptic Ocumeter Plus presentations were discontinued in July 2023.
    • Greenstone has timolol available.
    • Rising has timolol available.
    • Sandoz has timolol available.

Available Products

    • Timoptic in Ocudose, Bausch Health, 0.25%, 0.3 mL foil wrap container, 60 count, NDC 00187-1498-25
    • Timoptic in Ocudose, Bausch Health, 0.5%, 0.3 mL foil wrap container, 60 count, NDC 24208-0499-68
    • Timolol, Apotex, 0.5%, 2.5 mL bottle, 1 count, NDC 60505-1005-04
    • Timolol, Apotex, 0.5%, 5 mL bottle, 1 count, NDC 60505-1005-01
    • Timolol, Bausch Health, 0.5%, 2.5 mL bottle, 1 count, NDC 68682-0045-25
    • Timolol, Bausch Health, 0.5%, 5 mL bottle, 1 count, NDC 68682-0045-50
    • Timolol, Greenstone (Viatris), 0.25%, 10 mL bottle, 1 count, NDC 60758-0802-10
    • Timolol, Greenstone (Viatris), 0.25%, 5 mL bottle, 1 count, NDC 60758-0802-05
    • Timolol, Greenstone (Viatris), 0.5%, 10 mL bottle, 1 count, NDC 60758-0801-10
    • Timolol, Greenstone (Viatris), 0.5%, 5 mL bottle, 1 count, NDC 60758-0801-05
    • Timolol, Rising Pharmaceuticals, 0.25%, 10 mL bottle, 1 count, NDC 64980-0513-10
    • Timolol, Rising Pharmaceuticals, 0.25%, 15 mL bottle, 1 count, NDC 64980-0513-15
    • Timolol, Rising Pharmaceuticals, 0.25%, 5 mL bottle, 1 count, NDC 64980-0513-05
    • Timolol, Rising Pharmaceuticals, 0.5%, 10 mL bottle, 1 count, NDC 64980-0514-10
    • Timolol, Rising Pharmaceuticals, 0.5%, 15 mL bottle, 1 count, NDC 64980-0514-15
    • Timolol, Rising Pharmaceuticals, 0.5%, 5 mL bottle, 1 count, NDC 64980-0514-05
    • Timolol, Sandoz, 0.25%, 10 mL bottle, 1 count, NDC 61314-0226-10
    • Timolol, Sandoz, 0.25%, 15 mL bottle, 1 count, NDC 61314-0226-15
    • Timolol, Sandoz, 0.25%, 5 mL bottle, 1 count, NDC 61314-0226-05
    • Timolol, Sandoz, 0.5%, 10 mL bottle, 1 count, NDC 61314-0227-10
    • Timolol, Sandoz, 0.5%, 15 mL bottle, 1 count, NDC 61314-0227-15
    • Timolol, Sandoz, 0.5%, 5 mL bottle, 1 count, NDC 61314-0227-05

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated September 2, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 18, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.

ADVERTISEMENT